COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,186 Articles (22,197 medRxiv, 7,989 bioRxiv)

Most recent first Previous |  Page 1316: Articles 13151-13160  | Next

A proteomic survival predictor for COVID-19 patients in intensive care
Demichev, V., Tober-Lau, P., Nazarenko, T., Kaur Aulakh, S., Whitwell, H., Lemke, O., Roehl, A., Freiwald, A., Mittermaier, M., Szyrwiel, L., Ludwig, D., Correia-Melo, C., Lippert, L., Helbig, E. T., Stubbemann, P., Olk, N., Thibeault, C., Gruening, N.-M., Blyuss, O., Vernardis, S., White, M., Messner, C. B., Joannidis, M., Sonnweber, T., Klein, S. J., Pizzini, A., Wohlfarter, Y., Sahanic, S., Hilbe, R., Schaefer, B., Wagner, S., Machleidt, F., Garcia, C., Ruwwe-Gloesenkamp, C., Lingscheid, T., Bosquillon de Jarcy, L., Stegemann, M., Pfeiffer, M., Juergens, L., Denker, S., Zickler, D., Spies, C., Edel, A., B. Mueller, N., Enghard, P., Zelezniak, A., Bellmann-Weiler, R., Weiss, G., Campbell, A., Hayward, C., Porteous, D. J., Marioni, R. E., Uhrig, A., Zoller, H., Loeffler-Ragg, J., Keller, M. A., Tancevski, I., Timms, J. F., Zaikin, A., Hippenstiel, S., Ramharter, M., Mueller-Redetzky, H., Witzenrath, M., Suttorp, N., Lilley, K., Muelleder, M., Sander, L. E., PA-COVID- Study group, , Kurth, F., Ralser, M.
10.1101/2021.06.24.21259374 — Posted: 2021-06-26
The accuracy of saliva versus nasopharyngeal and/or oropharyngeal samples for the detection of SARS-CoV-2 in children. A rapid systematic review and meta-analysis
Dhillon, S. K., Schelstraete, P., Cornelissen, L., Lafort, Y., Bonde, J., Arbyn, M.
10.1101/2021.06.21.21259284 — Posted: 2021-06-26
Progression and Resolution of SARS-1 CoV-2 Infection in Golden Syrian Hamsters
Mulka, K., Beck, S., Solis, C., Johanson, A., Queen, S., McCarron, M., Richardson, M., Zhou, R., Marinho, P., Jedlicka, A., Guerrero-Martin, S., Shirk, E., Braxton, A., Brockhurst, J., Creisher, P., Dhakal, S., Brayton, C., Veenhuis, R., Metcalf Pate, K., Karakousis, P., Klein, S. L., Tarwater, P., Pekosz, A., Villano, J., Jain, S. K., Mankowski, J.
10.1101/2021.06.25.449918 — Posted: 2021-06-26
Expert Opinion on COVID-19 Vaccination and the Use of Cladribine Tablets in Clinical Practice
Rieckmann, P., Centonze, D., Giovannoni, G., Hua, L. H., Oreja-Guevara, C., Selchen, D., Soelberg Sorensen, P., Vermersch, P., Wiendl, H., Salloukh, H., Yammout, B. I.
10.1101/2021.06.22.21259308 — Posted: 2021-06-25
Association between SARS-Cov-2 infection during pregnancy and adverse pregnancy outcomes: a re-analysis of data from Wei et al. (2021).
Ludwig Serge, A. G., Simon, E., Bouit, C., Serrand, M., Filipuzzi, L., Astruc, K., Kadhel, P., Sagot, P.
10.1101/2021.06.22.21259302 — Posted: 2021-06-25
Identification of driver genes for severe forms of COVID-19 in a deeply phenotyped young patient cohort
Carapito, R., Li, R., Helms, J., Carapito, C., Gujja, S., Rolli, V., Guimaraes, R., Malagon-Lopez, J., Spinnhirny, P., Mohseninia, R., Hirschler, A., Muller, L., Bastard, P., Gervais, A., Zhang, Q., Danion, F., Ruch, Y., Schenck-Dhif, M., Collange, O., Chamaraux-Tran, T.-N., Molitor, A., Pichot, A., Bernard, A., Tahar, O., Bibi-Triki, S., Wu, H., Paul, N., Mayeur, S., Larnicol, A., Laumond, G., Frappier, J., Schmidt, S., Hanauer, A., Macquin, C., Stemmelen, T., Simons, M., Mariette, X., Hermine, O., Fafi-Kremer, S., Goichot, B., Drenou, B., Kuteifan, K., Pottecher, J., Mertes, P.-M., Kailasan
10.1101/2021.06.21.21257822 — Posted: 2021-06-25
Enhanced FcγRIII/CD16 activation by discrete ligands as independent correlates of disease severity in COVID-19 patients
Ankerhold, J., Giese, S., Kolb, P., Maul-Pavicic, A., Goeppert, N., Ciminski, K., Kreutz, C., Lother, A., Salzer, U., Bildl, W., Welsink, T., Morgenthaler, N., Busse Grawitz, A., Huzly, D., Schwemmle, M., Hengel, H., Falcone, V.
10.1101/2021.06.25.449893 — Posted: 2021-06-25
Use of hiPSC-derived cardiomyocytes to rule out proarrhythmic effects of drugs: the case of hydroxychloroquine in COVID-19
Sala, L., Leonov, V., Mura, M., Moretti, A., Crotti, L., Gnecchi, M., Schwartz, P. J.
10.1101/2021.06.25.449913 — Posted: 2021-06-25
Drug repurposing based on a Quantum-Inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2 including vitamin B12
Jimenez-Guardeno, J. M., Ortega-Prieto, A. M., Menendez Moreno, B., Maguire, T. J. A., Diaz Hernandez, J. I., Diez Perez, J., Zuckerman, M., Mercadal Playa, A., Cordero Deline, C., Malim, M. H., Martinez-Nunez, R. T.
10.1101/2021.06.25.449609 — Posted: 2021-06-25
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection
Patterson, B., Francisco, E. B., Yogendra, R., Long, E., Pise, A., Rodrigues, H., Hall, E., Herrera, o., Parikh, P., Guevara-Coto, J., Chang, X., Sacha, J. B., Rodriguez, R., Mora, J.
10.1101/2021.06.25.449905 — Posted: 2021-06-25 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).